1. Executive summery 
	2. Cardiac surgical devices market overview
	2.1. Introduction
	2.2. value chain analysis
	2.2.1. Suppliers
	2.2.2. Manufacturers
	2.2.3. Distributers
	2.2.4. Retailers
	2.2.5. End Users
	2.2.5.1. Diagnostic centers 
	2.2.5.2. Hospitals
	2.2.5.3. Patients 
	2.3. Research and developments
	2.4. Key buying criteria
	2.4.1. Objective
	2.4.2. Price
	2.4.3. Technology
	2.4.4. Availability 
	2.4.5. Health concern
	3. Market determinants 
	3.1. Key Motivators
	3.2. Factors restraining the growth of healthcare Robotic market
	3.3. Key opportunities
	3.4. Key challenges
	4. Market segmentation
	4.1.  Type of cardiac surgery 
	4.1.1. Coronary Artery Bypass Grafting (CABG)
	4.1.2. Transmyocardial Laser Revascularization (TMR)
	4.1.3. Heart Valve Repair or Replacement
	4.1.4. Arrhythmia Treatment
	4.1.5. Aneurysm Repair
	4.1.6. Heart Transplant
	4.1.7. Surgery To Place Ventricular Assist Devices or Total Artificial Hearts
	4.2. Surgical approaches
	4.2.1. Open-Heart Surgery
	4.2.2. Off-Pump Heart Surgery
	4.2.3. Minimally Invasive Heart Surgery
	4.3. Risk associated with different surgical procedure 
	4.4. Device types by application
	4.4.1. Imaging device
	4.4.1.1. Still imaging
	4.4.1.2. Real time imaging
	4.4.2. Cardiovascular stent
	4.4.2.1. Stent graft
	4.4.2.2. Self expanding stent
	4.4.3. Catheter
	4.4.4. Cardiac rhythm management devices 
	4.4.5. Surgical devices  
	4.4.6. Monitoring  devices
	5. Cost analysis  
	5.1. Cost of surgery 
	5.2. Device cost analysis
	5.3.  Recovery 
	6. Market strategies 
	6.1. Key strategies
	6.2. Recent Activities by companies
	6.3. Strategic recommendation 
	7. Market share 
	7.1. Key company analysis
	7.2. Key strategies 
	8. Geography analysis
	8.1. North America
	8.1.1. U.S.
	8.1.2. Canada
	8.2. Europe
	8.2.1. UK
	8.2.2. Germany
	8.2.3. Italy
	8.2.4. France
	8.2.5. Spain
	8.2.6. Roe
	8.3. APAC
	8.3.1. China
	8.3.2. Japan
	8.3.3. India
	8.3.4. South Korea
	8.3.5. Taiwan
	8.3.6. RoA
	8.4.  ROW 
	9. Patent Analysis 
	9.1. Patent analysis by technology
	9.2. Patent Analysis by Company 
	10. Corporate profile
	10.1. ABBOTT CARDIOVASCULAR
	10.2. BOSTON SCIENTIFIC CORP.
	10.3. C.R. BARD, INC.
	10.4. COOK MEDICAL
	10.5. MEDTRONIC. INC
	10.6.  TOSHIBA CORP
	10.7. COVIDIEN 
	10.8.  BIOSENSE WEBSTER, INC.
	10.9.  EDWARDS LIFESCIENCE CORP.
	10.10. PLC MEDICAL SYSTEMS